These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23542582)

  • 1. Structure-guided engineering of Anticalins with improved binding behavior and biochemical characteristics for application in radio-immuno imaging and/or therapy.
    Eggenstein E; Eichinger A; Kim HJ; Skerra A
    J Struct Biol; 2014 Feb; 185(2):203-14. PubMed ID: 23542582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities.
    Skerra A
    FEBS J; 2008 Jun; 275(11):2677-83. PubMed ID: 18435758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial design of an Anticalin directed against the extra-domain b for the specific targeting of oncofetal fibronectin.
    Gebauer M; Schiefner A; Matschiner G; Skerra A
    J Mol Biol; 2013 Feb; 425(4):780-802. PubMed ID: 23238252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-affinity recognition of lanthanide(III) chelate complexes by a reprogrammed human lipocalin 2.
    Kim HJ; Eichinger A; Skerra A
    J Am Chem Soc; 2009 Mar; 131(10):3565-76. PubMed ID: 19227970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallographic analysis of an "anticalin" with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region.
    Korndörfer IP; Beste G; Skerra A
    Proteins; 2003 Oct; 53(1):121-9. PubMed ID: 12945055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigenin.
    Schlehuber S; Beste G; Skerra A
    J Mol Biol; 2000 Apr; 297(5):1105-20. PubMed ID: 10764576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticalins small engineered binding proteins based on the lipocalin scaffold.
    Gebauer M; Skerra A
    Methods Enzymol; 2012; 503():157-88. PubMed ID: 22230569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The menagerie of human lipocalins: a natural protein scaffold for molecular recognition of physiological compounds.
    Schiefner A; Skerra A
    Acc Chem Res; 2015 Apr; 48(4):976-85. PubMed ID: 25756749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticalins: exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins.
    Richter A; Eggenstein E; Skerra A
    FEBS Lett; 2014 Jan; 588(2):213-8. PubMed ID: 24239535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuning ligand affinity, specificity, and folding stability of an engineered lipocalin variant -- a so-called 'anticalin' -- using a molecular random approach.
    Schlehuber S; Skerra A
    Biophys Chem; 2002 May; 96(2-3):213-28. PubMed ID: 12034442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput sorting of an Anticalin library via EspP-mediated functional display on the Escherichia coli cell surface.
    Binder U; Matschiner G; Theobald I; Skerra A
    J Mol Biol; 2010 Jul; 400(4):783-802. PubMed ID: 20630471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of an artificial receptor protein ("anticalin") based on the human apolipoprotein D.
    Vogt M; Skerra A
    Chembiochem; 2004 Feb; 5(2):191-9. PubMed ID: 14760740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticalin® proteins: from bench to bedside.
    Deuschle FC; Ilyukhina E; Skerra A
    Expert Opin Biol Ther; 2021 Apr; 21(4):509-518. PubMed ID: 33074019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA).
    Barinka C; Ptacek J; Richter A; Novakova Z; Morath V; Skerra A
    Protein Eng Des Sel; 2016 Mar; 29(3):105-15. PubMed ID: 26802163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide.
    Rauth S; Hinz D; Börger M; Uhrig M; Mayhaus M; Riemenschneider M; Skerra A
    Biochem J; 2016 Jun; 473(11):1563-78. PubMed ID: 27029347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticalins as alternative binding proteins for therapeutic use.
    Skerra A
    Curr Opin Mol Ther; 2007 Aug; 9(4):336-44. PubMed ID: 17694446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational engineering of a fluorescein-binding anticalin for improved ligand affinity.
    Vopel S; Mühlbach H; Skerra A
    Biol Chem; 2005 Nov; 386(11):1097-104. PubMed ID: 16307475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drastic alterations in the loop structure around colchicine upon complex formation with an engineered lipocalin indicate a conformational selection mechanism.
    Jerschke E; Eichinger A; Skerra A
    Acta Crystallogr F Struct Biol Commun; 2023 Sep; 79(Pt 9):231-239. PubMed ID: 37584182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural plasticity in the loop region of engineered lipocalins with novel ligand specificities, so-called Anticalins.
    Achatz S; Jarasch A; Skerra A
    J Struct Biol X; 2022; 6():100054. PubMed ID: 34988429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the human odorant binding protein, OBPIIa.
    Schiefner A; Freier R; Eichinger A; Skerra A
    Proteins; 2015 Jun; 83(6):1180-4. PubMed ID: 25810031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.